Actively Recruiting
A Long-Term Follow-up Study for Subjects Previously Treated With A Century Therapeutics Cellular Therapy Product
Led by Century Therapeutics, Inc. · Updated on 2025-06-25
375
Participants Needed
7
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to collect long-term safety and survival information from people who were treated previously with cellular therapy products in a Century Therapeutics-sponsored study. It focuses on monitoring any late side effects or risks that may arise after such treatments, especially those involving induced pluripotent stem cell (iPSC)-derived, genome-edited cellular therapies. The study helps understand long-term outcomes related to these advanced cellular treatments for hematological and solid tumor malignancies. Participants who received at least one dose of these cellular therapy products in earlier eligible Century trials will be followed for up to 180 months after their last treatment. This is an observational study with no new treatments given. During this time, researchers will track safety events, survival, and the persistence of the cellular product in the body. Throughout the study, participants will attend scheduled visits for safety monitoring, including checking for any special adverse events and serious side effects possibly related to the cellular therapy. Researchers will also observe overall survival and measure how long the cellular product remains in the participant. The study involves no intervention and continues until 180 months or death, whichever comes first.
CONDITIONS
Brief Title
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant has provided written informed consent prior to any long-term follow-up study procedures
- Participants received at least one treatment with a cellular therapy product in an eligible index trial
- Participant was withdrawn, early discontinued, or completed an eligible index trial
- Participant is willing and able to comply with scheduled visits, study plan, and other study procedures
You will not qualify if you...
- This study has no exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 180 months
Participants who have previously received a cellular therapy product in an eligible trial will be followed for safety and survival outcomes for up to 180 months.
Trial Site Locations
Total: 7 locations
1
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States, 85234
Not Yet Recruiting
2
University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033
Not Yet Recruiting
3
University of Maryland Medical Center
Baltimore, Maryland, United States, 21201
Actively Recruiting
4
Corewell Health
Grand Rapids, Michigan, United States, 49503
Not Yet Recruiting
5
Levine Cancer Institute
Charlotte, North Carolina, United States, 28204
Actively Recruiting
6
University of Cincinnati Medical Center
Cincinnati, Ohio, United States, 45229
Actively Recruiting
7
Swedish Cancer Institute
Seattle, Washington, United States, 98104
Actively Recruiting
Research Team
C
Century Therapeutics Clinical Team
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here